tiprankstipranks
Trending News
More News >
Immuneering (IMRX)
NASDAQ:IMRX
US Market

Immuneering (IMRX) Revenue

Compare
587 Followers

Immuneering Revenue

Immuneering had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Immuneering had annual revenue of 0.00 with ― growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Revenue/Employee
$0
Employees
54
Market Cap
$381.61M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
Dec 31, 2023
-316.95K
Dec 31, 2022
316.95K-1.76M+15.24%
Dec 31, 2021
2.08M-231.57K+89.98%
Dec 31, 2020
2.31M391.83K+120.41%
Dec 31, 2019
1.92M